127 related articles for article (PubMed ID: 1732363)
1. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone.
Calkins H; Sousa J; el-Atassi R; Schmaltz S; Kadish A; Morady F
J Am Coll Cardiol; 1992 Feb; 19(2):347-52. PubMed ID: 1732363
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia.
Morady F; Kou WH; Kadish AH; Nelson SD; Toivonen LK; Kushner JA; Schmaltz S; de Buitleir M
J Am Coll Cardiol; 1988 Aug; 12(2):388-94. PubMed ID: 3392332
[TBL] [Abstract][Full Text] [Related]
3. Epinephrine infusions during antiarrhythmic drug evaluations: toward a better understanding of drug activity.
DiMarco JP
J Am Coll Cardiol; 1992 Feb; 19(2):353-4. PubMed ID: 1732364
[No Abstract] [Full Text] [Related]
4. Effects of epinephrine in patients with an accessory atrioventricular connection treated with quinidine.
Morady F; Kou WH; Kadish AH; Toivonen LK; Kushner JA; Schmaltz S
Am J Cardiol; 1988 Sep; 62(9):580-4. PubMed ID: 3414550
[TBL] [Abstract][Full Text] [Related]
5. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
Chiamvimonvat N; Mitchell LB; Gillis AM; Wyse DG; Sheldon RS; Duff HJ
Am J Cardiol; 1992 Sep; 70(6):598-604. PubMed ID: 1324598
[TBL] [Abstract][Full Text] [Related]
6. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL
Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732
[TBL] [Abstract][Full Text] [Related]
7. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
Toivonen L; Kadish A; Morady F
Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
9. Drug response at electropharmacologic study in patients with ventricular tachyarrhythmias: the importance of ventricular refractoriness.
Gillis AM; Wyse DG; Duff HJ; Mitchell LB
J Am Coll Cardiol; 1991 Mar; 17(4):914-20. PubMed ID: 1999629
[TBL] [Abstract][Full Text] [Related]
10. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
11. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
Veltri EP; Reid PR; Platia EV; Griffith LS
Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone therapy: role of early and late electrophysiologic studies.
Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH
J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
[TBL] [Abstract][Full Text] [Related]
14. The effect of rate on prolongation of ventricular refractoriness by quinidine in humans.
Rosenheck S; Sousa J; Calkins H; Kadish AH; Morady F
Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 1):1379-84. PubMed ID: 1701891
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
Kalbfleisch SJ; Williamson B; Man KC; Vorperian V; Hummel JD; Hasse C; Strickberger SA; Calkins H; Langberg JJ; Morady F
J Am Coll Cardiol; 1993 Nov; 22(6):1723-9. PubMed ID: 8227846
[TBL] [Abstract][Full Text] [Related]
17. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
Masotti CS; Pierangeli A
Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
[TBL] [Abstract][Full Text] [Related]
18. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME
Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
[TBL] [Abstract][Full Text] [Related]
19. Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia.
Sheldon RS; Rahmberg M; Duff HJ
J Cardiovasc Pharmacol; 1990 Nov; 16(5):818-23. PubMed ID: 1703606
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
Saksena S; Rothbart ST; Shah Y; Cappello G
Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
